$AMBS - Elto Pharma Wonder if that valuation was
Post# of 30027
(Total Views: 444)
Posted On: 04/20/2018 12:41:49 AM
$AMBS - Elto Pharma
Wonder if that valuation was for the US only or if the many many many mesnt Europe, Asia & US?
MARCH 08, 2018
Elto Pharma Receives Notice of Allowance in Australia for Patent Covering Eltoprazine in the Treatment of Parkinson's Levodopa-induced Dyskinesia
https://www.amarantus.com/news/press-releases...tralia-for
DECEMBER 08, 2017
Amarantus Subsidiary Elto Pharma Announces the Issuance of Patents in Singapore and New Zealand Covering Treatment of Parkinson’s LID
https://www.amarantus.com/news/press-releases...ssuance-of
DECEMBER 05, 2017
Amarantus Subsidiary Elto Pharma Receives Notice of Allowance for European Patent Application Covering Method of Treating Cognitive Impairment Associated with Alzheimer's Disease and Parkinson's disease with Eltoprazine
https://www.amarantus.com/news/press-releases...-notice-of
FEBRUARY 10, 2016
Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia
https://www.amarantus.com/news/press-releases...the-us-fda
DECEMBER 15, 2015
Amarantus Receives Notice of Allowance for U.S. Patent Application Covering Method of Treating Parkinson's Disease Levodopa-induced Dyskinesia (PD-LID)
Patent issuance will provide additional IP protection for eltoprazine, lead product candidate, through 2027
https://www.amarantus.com/news/press-releases...u-s-patent
OCTOBER 29, 2015
Amarantus Announces Issuance of Australian Patent No. 61/057,713 Covering Eltoprazine Treatment of Parkinson’s Disease and Alzheimer’s Disease
https://www.amarantus.com/news/press-releases...-patent-no
JUNE 30, 2015
Amarantus Announces Issuance of United States Patent No. 9,066,903 Covering Proprietary Methods of Administration of Eltoprazine for the Treatment of Parkinson's Disease
https://www.amarantus.com/news/press-releases...-patent-no
MAY 13, 2015
Amarantus Receives Notice of Allowance for U.S. Patent Application Covering Proprietary Methods of Administration and Compositions in the Treatment of Parkinson's Disease
https://www.amarantus.com/news/press-releases...u-s-patent
Just to name a few....
Aloha
Wonder if that valuation was for the US only or if the many many many mesnt Europe, Asia & US?
MARCH 08, 2018
Elto Pharma Receives Notice of Allowance in Australia for Patent Covering Eltoprazine in the Treatment of Parkinson's Levodopa-induced Dyskinesia
https://www.amarantus.com/news/press-releases...tralia-for
DECEMBER 08, 2017
Amarantus Subsidiary Elto Pharma Announces the Issuance of Patents in Singapore and New Zealand Covering Treatment of Parkinson’s LID
https://www.amarantus.com/news/press-releases...ssuance-of
DECEMBER 05, 2017
Amarantus Subsidiary Elto Pharma Receives Notice of Allowance for European Patent Application Covering Method of Treating Cognitive Impairment Associated with Alzheimer's Disease and Parkinson's disease with Eltoprazine
https://www.amarantus.com/news/press-releases...-notice-of
FEBRUARY 10, 2016
Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia
https://www.amarantus.com/news/press-releases...the-us-fda
DECEMBER 15, 2015
Amarantus Receives Notice of Allowance for U.S. Patent Application Covering Method of Treating Parkinson's Disease Levodopa-induced Dyskinesia (PD-LID)
Patent issuance will provide additional IP protection for eltoprazine, lead product candidate, through 2027
https://www.amarantus.com/news/press-releases...u-s-patent
OCTOBER 29, 2015
Amarantus Announces Issuance of Australian Patent No. 61/057,713 Covering Eltoprazine Treatment of Parkinson’s Disease and Alzheimer’s Disease
https://www.amarantus.com/news/press-releases...-patent-no
JUNE 30, 2015
Amarantus Announces Issuance of United States Patent No. 9,066,903 Covering Proprietary Methods of Administration of Eltoprazine for the Treatment of Parkinson's Disease
https://www.amarantus.com/news/press-releases...-patent-no
MAY 13, 2015
Amarantus Receives Notice of Allowance for U.S. Patent Application Covering Proprietary Methods of Administration and Compositions in the Treatment of Parkinson's Disease
https://www.amarantus.com/news/press-releases...u-s-patent
Just to name a few....
Aloha
(2)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼